Partners
The International Horizon Scanning Initiative (IHSI) is a collaborative effort uniting national health authorities, HTA bodies, and policymakers to enhance pharmaceutical market transparency and strengthen decision-making in healthcare planning. As a member-driven organization, IHSI brings together key stakeholders who share a commitment to independent, high-quality data for horizon scanning and policy formulation.
Through combining the experience of nine experiences horizon scanning systems, IHSI develops the best-in-class pharmaceutical intelligence, ensuring that its members can anticipate and respond effectively to emerging health technologies. Our partners play a vital role in maintaining the integrity, independence, and accuracy of our data-driven approach.
Who Are Our Partners?
IHSI is a member state-owned and operated organization. Our partners consist of national ministries of health, health technology assessment (HTA) agencies, and payer organizations. Each member state nominates a representative entity, known as a full member, which directly engages with IHSI’s governance structures and database resources. Additionally, affiliate members may be nominated by full members, provided they meet IHSI’s strict non-industry, non-profit participation criteria.
These partners work together to ensure that healthcare systems are equipped with reliable, transparent, and actionable intelligence for pharmaceutical policy and planning.
Full Members
- The Dutch National Healthcare Institute, Netherlands
- Danish Medicines Agency, Denmark
- National Institute for Health and Disability Insurance, Belgium
- National Authority of Medicines and Health Products, Portugal
- Federal Office of Public Health, Switzerland
- Norwegian Medical Products Agency, Norway
- Federal Ministry for Social Affairs, Health, Care and Consumer Protection, Austria
- Department of Health, Ireland
- Ministry of Health and Social Affairs, Sweden
Affiliate Members:
Austria:
- Austrian Institute for Health Technology Assessment (AIHTA)
- Burgenländischer Gesundheitsfonds (BURGEF)
- Bundesversicherungsanstalt öffentlich Bediensteter
- Dachverband der Sozialversicherungsträger
- Gesundheit Österreich GmbH (GÖG)
- NÖ Landesgesundheitsagentur
- OÖ Gesundheitsholding GmbH
- Österreichische Gesundheitskasse (ÖGK)
- Salzburger Gesundheitsfonds (SAGES)
- SVS Sozialversicherung der Selbstständigen
- Tirol Kliniken GmbH
- Wiener Gesundheitsfonds
- Wiener Gesundheitsverbund (WIGEV)
Belgium:
Denmark:
- Amgros I/S, Denmark
- Danish Medicines Council
- The Danish Health Data Authority (DHDA)
- The Danish Healthcare Quality Institute
Ireland:
- Acute Hospital Drugs Management Programme
- Corporate Pharmaceutical Unit
- National Centre for Pharmacoeconomics
Norway:
Sweden:
- Dental and Pharmaceutical Benefits Agency (TLV)
- Region Blekinge
- Region Dalarna
- Region Gotland
- Region Halland
- Region Jämtland Härjedalen
- Region Kalmar län
- Region Kronoberg
- Region Norrbotten
- Region Örebro län
- Region Östergötland
- Region Skåne
- Region Sörmland
- Region Stockholm
- Region Uppsala
- Region Värmland
- Region Västernorrland
- Region Västmanland
- Region Västra Götaland
- National Board of Health and Welfare (Socialstyrelsen)
- Swedish Association of Local Authorities and Regions
Benefits of Partnership
Joining IHSI provides member organizations with unparalleled access to a cutting-edge pharmaceutical horizon scanning system, built on a foundation of transparency, independence, and best-in-class technology. Key benefits include:tes also contribute through dedicated personnel and expertise in horizon scanning and HTA activities.
- Direct Access to the IHSI Database – Members can leverage a powerful data repository containing structured, continuously updated records on pharmaceutical developments, from clinical trial phase I through market approval.
- High-Impact Reports (HIRs) – Exclusive access to in-depth, expert-reviewed analyses of emerging high-impact pharmaceutical products, covering their potential clinical, organizational, and financial implications.
- Enhanced Negotiation Leverage – Members gain insights into anticipated price requests, estimated approval timelines, and market access dynamics, helping national payer organizations make informed procurement and reimbursement decisions.
- AI-Powered Data Curation & Analysis – Our advanced AI, NLP, and machine learning algorithms ensure accurate and up-to-date data, validated by subject matter experts and key opinion leaders across various therapeutic areas.
- Collaboration & Knowledge Sharing – Members participate in cross-border collaboration, exchanging knowledge and best practices with leading experts in pharmaceutical policy, health economics, and regulatory affairs.
- Member states also contribute through dedicated personnel and expertise in horizon scanning and HTA activities.
How to Join IHSI
Becoming a partner of IHSI is an opportunity for national healthcare agencies to gain access to the most comprehensive pharmaceutical intelligence system available. The membership process involves:
- Eligibility Assessment – National ministries of health or authorized non-profit HTA organizations can apply for membership.
- Nomination Process – Each member state designates a full member organization, with the possibility of nominating affiliate members under strict eligibility criteria.
- Approval & Onboarding – Upon acceptance, new members receive access to IHSI’s database, high-impact reports, and collaborative working groups.
- Active Engagement – Members contribute to database governance, quality management committees, and working groups, ensuring continued development and improvement of the IHSI system.
- Member states also contribute through dedicated personnel and expertise in horizon scanning and HTA activities.
Partnering for a Stronger Future
IHSI is built on the collective strength of its member states. By working together, we create a data-driven ecosystem that empowers governments and policymakers to shape healthcare systems that are resilient, transparent, and patient-focused.
We welcome new partners who share our vision of enhancing pharmaceutical market intelligence and ensuring the best outcomes for healthcare systems and patients. For more information on joining IHSI, please contact us to explore how your organization can contribute to and benefit from this groundbreaking initiative.Member states also contribute through dedicated personnel and expertise in horizon scanning and HTA activities.
